| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
31,570,000 |
| Market
Cap: |
15.79(M) |
| Last
Volume: |
540,567 |
Avg
Vol: |
539,072 |
| 52
Week Range: |
$0.1483 - $3.06 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile BrainStorm Cell Therapeutics is a biotechnology company engaged in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases including: Amyotrophic Lateral Sclerosis; Progressive Multiple Sclerosis; Alzheimer's disease; and other neurodegenerative diseases. NurOwn®, Co.'s proprietary platform, utilizes cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival and improve neurological function.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
11,500 |
11,500 |
| Total Buy Value |
$0 |
$0 |
$20,402 |
$20,402 |
| Total People Bought |
0 |
0 |
1 |
1 |
| Total Buy Transactions |
0 |
0 |
1 |
1 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Polverino Anthony J. |
Director |
– • – |
2021-12-15 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
22,078 |
|
- |
|
| Taub Malcolm S |
Director |
– • – |
2021-12-15 |
4 |
A |
$0.00 |
$0 |
D/D |
12,000 |
77,332 |
|
- |
|
| Almenoff June Sherie |
Director |
– • – |
2021-12-15 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
6,000 |
|
- |
|
| Almenoff June Sherie |
Director |
– • – |
2021-12-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
4,000 |
|
- |
|
| Taub Malcolm S |
Director |
– • – |
2021-12-10 |
4 |
A |
$0.00 |
$0 |
D/D |
12,000 |
65,332 |
|
- |
|
| Abbhi Sankesh |
Director |
– • – |
2021-12-10 |
4 |
A |
$0.00 |
$0 |
D/D |
6,666 |
11,323 |
|
- |
|
| Lebovits Chaim |
Chief Executive Officer |
• – – |
2021-12-10 |
4 |
A |
$0.00 |
$0 |
D/D |
31,185 |
155,925 |
|
- |
|
| Kern Ralph Dr. |
COO and Chief Medical Officer |
• – – |
2021-12-10 |
4 |
A |
$0.00 |
$0 |
D/D |
35,885 |
187,425 |
|
- |
|
| Polverino Anthony J. |
Director |
– • – |
2021-12-10 |
4 |
A |
$0.00 |
$0 |
D/D |
4,216 |
20,078 |
|
- |
|
| Shah Preetam |
EVP, CFO and Treasurer |
• – – |
2020-12-30 |
4 |
D |
$4.64 |
$116,000 |
D/D |
(25,000) |
11,600 |
|
- |
|
| Waclawski Anthony |
See Remarks |
• – – |
2020-09-08 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
35,000 |
|
- |
|
| Lebovits Chaim |
Chief Executive Officer |
• – – |
2020-07-26 |
4 |
A |
$0.00 |
$0 |
D/D |
31,185 |
124,740 |
|
- |
|
| Acc International Holdings Ltd. |
Member of 10% owner group |
– – – |
2020-07-16 |
4 |
S |
$13.47 |
$105,351 |
D/D |
(7,823) |
67,053 |
|
63% |
|
| Setboun David |
EVP and COO |
• – – |
2020-07-16 |
4 |
B |
$12.95 |
$64,740 |
D/D |
5,000 |
55,000 |
2.74 |
-63% |
|
| Acc International Holdings Ltd. |
Member of 10% owner group |
– – – |
2020-07-15 |
4 |
S |
$13.12 |
$241,715 |
D/D |
(18,430) |
74,876 |
|
60% |
|
| Abbhi Sankesh |
Director |
– • – |
2020-07-15 |
4 |
B |
$12.99 |
$607,659 |
I/I |
46,779 |
2,164,530 |
2.1 |
-60% |
|
| Acc International Holdings Ltd. |
Member of 10% owner group |
– – – |
2020-07-13 |
4 |
S |
$13.52 |
$540,952 |
D/D |
(40,000) |
93,306 |
|
66% |
|
| Acc International Holdings Ltd. |
Member of 10% owner group |
– – – |
2020-07-10 |
4 |
S |
$13.35 |
$26,700 |
D/D |
(2,000) |
133,306 |
|
68% |
|
| Acc International Holdings Ltd. |
Member of 10% owner group |
– – – |
2020-07-09 |
4 |
S |
$13.13 |
$45,939 |
D/D |
(3,500) |
135,306 |
|
70% |
|
| Yablonka Uri |
EVP & Chief Business Officer |
• • – |
2020-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
17,543 |
|
- |
|
| Lindborg Stacy |
EVP, Head Global Clin Research |
• – – |
2020-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
25,000 |
|
- |
|
| Setboun David |
EVP and COO |
• – – |
2020-04-07 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
50,000 |
|
- |
|
| Abbhi Sankesh |
Director |
– • – |
2020-04-06 |
4 |
A |
$0.00 |
$0 |
D/D |
4,657 |
4,657 |
|
- |
|
| Abbhi Sankesh |
Director |
– • – |
2020-03-30 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,117,751 |
|
161% |
|
| Kern Ralph Dr. |
COO and Chief Medical Officer |
• – – |
2020-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
35,885 |
151,540 |
|
- |
|
211 Records found
|
|
Page 2 of 9 |
|
|
0.05 (8.74%) 
